title: Cost benefit analysis of two policy options for cannabis: status quo and legalisation.
abstract: OBJECTIVE
  To date there has been limited analysis of the economic costs and benefits associated with cannabis legalisation. This study redresses this gap. A cost benefit analysis of two cannabis policy options the status quo (where cannabis use is illegal) and a legalised-regulated option was conducted.
  
  
  METHODS
  A cost benefit analysis was used to value the costs and benefits of the two policies in monetary terms. Costs and benefits of each policy option were classified into five categories (direct intervention costs, costs or cost savings to other agencies, benefits or lost benefits to the individual or the family, other impacts on third parties, and adverse or spill over events). The results are expressed as a net social benefit (NSB).
  
  
  RESULTS
  The mean NSB per annum from Monte Carlo simulations (with the 5 and 95 percentiles) for the status quo was $294.6 million AUD ($201.1 to $392.7 million) not substantially different from the $234.2 million AUD ($136.4 to $331.1 million) for the legalised-regulated model which excludes government revenue as a benefit. When government revenue is included, the NSB for legalised-regulated is higher than for status quo. Sensitivity analyses demonstrate the significant impact of educational attainment and wellbeing as drivers for the NSB result.
  
  
  CONCLUSIONS
  Examining the percentiles around the two policy options, there appears to be no difference between the NSB for these two policy options. Economic analyses are essential for good public policy, providing information about the extent to which one policy is substantially economically favourable over another. In cannabis policy, for these two options this does not appear to be the case.
authors.affiliation: National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia.
authors.forename: Marian
authors.initials: M
authors.lastname: Shanahan
authors.affiliation: National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia.
authors.forename: Alison
authors.initials: A
authors.lastname: Ritter
mesh_terms: D002188:Cannabis; D003362:Cost-Benefit Analysis; D006291:Health Policy; D006801:Humans; D064086:Medical Marijuana / Q000191:economics*; D009010:Monte Carlo Method
chemical_list: D064086:Medical Marijuana
references.citation: Lancet. 2007 Jul 28;370(9584):319-28
references.pmid: 17662880
references.citation: Addiction. 2012 May;107(5):865-71
references.pmid: 21985069
references.citation: Health Econ. 2009 Feb;18(2):181-202
references.pmid: 18566968
references.citation: Health Educ Res. 2001 Aug;16(4):457-69
references.pmid: 11525392
references.citation: Curr Opin Psychiatry. 2009 May;22(3):258-62
references.pmid: 19293714
references.citation: BMJ. 2005 Dec 10;331(7529):1371
references.pmid: 16321993
references.citation: Accid Anal Prev. 2004 Mar;36(2):239-48
references.pmid: 14642878
references.citation: Health Serv Res. 2002 Apr;37(2):433-55
references.pmid: 12036002
references.citation: Health Econ. 2004 Feb;13(2):123-37
references.pmid: 14737751
references.citation: Aust N Z J Psychiatry. 2003 Feb;37(1):31-40
references.pmid: 12534654
references.citation: BMJ. 2002 Jan 12;324(7329):105-6
references.pmid: 11786459
references.citation: Health Econ. 2004 Sep;13(9):825-43
references.pmid: 15362176
references.citation: J Subst Abuse Treat. 2000 Mar;18(2):149-59
references.pmid: 10716098
references.citation: Science. 1989 Sep 1;245(4921):939-47
references.pmid: 2772647
references.citation: Tob Control. 2005 Aug;14(4):278-83
references.pmid: 16046692
references.citation: BJOG. 2002 Jan;109(1):21-7
references.pmid: 11843371
references.citation: Drug Alcohol Depend. 2010 Aug 1;110(3):247-53
references.pmid: 20456872
references.citation: Health Econ. 2010 Nov;19(11):1281-99
references.pmid: 19937639
references.citation: Accid Anal Prev. 2001 Nov;33(6):703-11
references.pmid: 11579972
references.citation: Drug Alcohol Depend. 2004 Jan 7;73(1):41-50
references.pmid: 14687958
references.citation: J Safety Res. 2007;38(6):669-74
references.pmid: 18054598
references.citation: Addiction. 2008 Apr;103(4):580-90
references.pmid: 18339104
references.citation: Addiction. 2009 Nov;104(11):1856-61
references.pmid: 19832786
references.citation: Aust N Z J Psychiatry. 2012 Dec;46(12):1182-92
references.pmid: 22984111
references.citation: Addiction. 1997 Nov;92(11):1553-60
references.pmid: 9519497
references.citation: J Health Econ. 2009 Jan;28(1):132-42
references.pmid: 18926578
references.citation: Addiction. 2006 Jun;101(6):873-82
references.pmid: 16696631
references.citation: BMJ. 2012 Jun 01;344:e3936
references.pmid: 22661743